• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS Back to Search Results
Catalog Number 04625374160
Device Problem Non Reproducible Results (4029)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 12/14/2018
Event Type  malfunction  
Manufacturer Narrative
Occupation - the occupation is lay user/patient.
 
Event Description
The patient stated that he received an erroneous result when testing with his coaguchek xs meter serial number (b)(4).A sample from the patient was tested using the meter at 8:57 a.M., resulting with a value of 4.4 inr.The doctor advised the patient to come into the doctor's office for another test.At around 2:15 p.M., a sample from the patient was tested using the doctor's coaguchek xs meter, resulting with a value of 1.5 inr.The doctor believed the 1.5 inr value to be correct.No adverse events were alleged to have occurred with the patient.The patient was not treated and did not have medication changed based on the meter result.The patient is currently feeling well.The patient stated that the doctor wants his inr levels to stay around 2.0 inr.The patient stated that the doctor is okay with an inr of 2.2, but not much higher than this.The patient's testing frequency is once per week.The patient is not anemic or polycythemic.The patient does not have antiphospholipid antibodies or lupus.The patient does not take heparin or direct thrombin inhibitors.The patient was taking 2.5 mg of warfarin per day.Due to a 4.0 inr result on (b)(6) 2018, the patient withheld warfarin on (b)(6) 2018.On (b)(6) 2018, the patient began rotating warfarin medication between 1.25 mg.And 2.5 mg.Every other day.The patient is not taking any new medications and has no new illnesses.The patient said that he had no changes in diet other than eating less lately.The patient had a nosebleed, but did not need medical treatment.The patient's product was requested for investigation.Relevant retention test strips (lot 353497) were tested in comparison with the master lot.For this purpose two human blood samples from marcumar donors and two internal reference meters were used.Retention samples were acceptable.No error messages occurred.
 
Manufacturer Narrative
The patient's meter was returned for investigation and was tested with qc material in combination with master lot strips.Testing results: qc 1: 2.6 inr, qc 2: 2.5 inr, qc 3: 2.6 inr.The obtained qc values were in the allowed range of the used combination master lot strip lot - qc lot.(1.9 - 2.9 inr).All measurements were without error messages.The maximum difference between measurements was 8.3 %.The results alleged by the customer were not observed in the meter¿s patient result memory.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK ® XS SYSTEM
Type of Device
PROTHROMBIN TIME TEST STRIPS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key8203744
MDR Text Key131772986
Report Number1823260-2018-05165
Device Sequence Number1
Product Code GJS
Combination Product (y/n)N
PMA/PMN Number
K062925
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Type of Report Initial,Followup
Report Date 01/16/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date04/30/2020
Device Catalogue Number04625374160
Device Lot Number35349723
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 12/17/2018
Initial Date FDA Received12/28/2018
Supplement Dates Manufacturer Received12/17/2018
Supplement Dates FDA Received01/16/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ATRIAL VALVE REPLACEMENT; COLCHICINE; FUROSEMIDE; METOPROLOL; PACEMAKER/ICD; PANTOPRAZOLE; RANITIDINE; TAMSULOSIN; ULORIC
Patient Age81 YR
-
-